BFB Health Limited (HKG:0205)
Hong Kong
· Delayed Price · Currency is HKD 0.710
+0.040 (5.97%)
Apr 29, 2026, 3:58 PM HKT
BFB Health Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 33.12 | 30.15 | 38.38 | 73.16 | 68.35 | Upgrade
|
| Revenue Growth (YoY) | 9.84% | -21.44% | -47.54% | 7.04% | -14.74% | Upgrade
|
| Cost of Revenue | 16.88 | 17.74 | 27.15 | 31.92 | 26.69 | Upgrade
|
| Gross Profit | 16.23 | 12.42 | 11.23 | 41.24 | 41.66 | Upgrade
|
| Selling, General & Admin | 19.82 | 24.79 | 47.89 | 25.14 | 28.95 | Upgrade
|
| Operating Expenses | 32.1 | 49.97 | 45.7 | 25.14 | 28.95 | Upgrade
|
| Operating Income | -15.87 | -37.55 | -34.47 | 16.1 | 12.71 | Upgrade
|
| Interest Expense | -2.01 | -1.92 | -1.86 | -1.68 | -2.3 | Upgrade
|
| Interest & Investment Income | - | 0.08 | 0.45 | 0.2 | 0.01 | Upgrade
|
| Earnings From Equity Investments | 1.7 | -22.53 | -5.27 | -2.71 | -11.59 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.22 | 2.12 | 2.69 | 16.15 | -7.18 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.68 | -6.85 | -6.15 | 2.47 | 1.47 | Upgrade
|
| EBT Excluding Unusual Items | -20.08 | -66.65 | -44.61 | 30.53 | -6.87 | Upgrade
|
| Gain (Loss) on Sale of Investments | 44.8 | 9.91 | 12.12 | -118.04 | -36.67 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.04 | 7.12 | 17.57 | -0.1 | - | Upgrade
|
| Asset Writedown | - | -9.53 | - | - | - | Upgrade
|
| Other Unusual Items | -44.25 | 29.74 | -25.55 | 0.32 | - | Upgrade
|
| Pretax Income | -19.57 | -29.4 | -40.47 | -87.29 | -43.54 | Upgrade
|
| Income Tax Expense | 0.43 | -0.52 | -3.07 | 1.97 | 1.05 | Upgrade
|
| Earnings From Continuing Operations | -19.99 | -28.88 | -37.4 | -89.26 | -44.59 | Upgrade
|
| Minority Interest in Earnings | 14.45 | -5.71 | 14.12 | 6.79 | 4.46 | Upgrade
|
| Net Income | -5.54 | -34.6 | -23.28 | -82.47 | -40.14 | Upgrade
|
| Net Income to Common | -5.54 | -34.6 | -23.28 | -82.47 | -40.14 | Upgrade
|
| Shares Outstanding (Basic) | 947 | 736 | 736 | 656 | 511 | Upgrade
|
| Shares Outstanding (Diluted) | 958 | 736 | 736 | 656 | 511 | Upgrade
|
| Shares Change (YoY) | 30.20% | - | 12.23% | 28.26% | 46.81% | Upgrade
|
| EPS (Basic) | -0.01 | -0.05 | -0.03 | -0.13 | -0.08 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.05 | -0.03 | -0.13 | -0.08 | Upgrade
|
| Free Cash Flow | - | 22.95 | -36.8 | -7.83 | -22.85 | Upgrade
|
| Free Cash Flow Per Share | - | 0.03 | -0.05 | -0.01 | -0.04 | Upgrade
|
| Gross Margin | 49.02% | 41.18% | 29.26% | 56.37% | 60.95% | Upgrade
|
| Operating Margin | -47.92% | -124.55% | -89.82% | 22.01% | 18.59% | Upgrade
|
| Profit Margin | -16.73% | -114.74% | -60.66% | -112.73% | -58.72% | Upgrade
|
| Free Cash Flow Margin | - | 76.13% | -95.89% | -10.70% | -33.43% | Upgrade
|
| EBITDA | -15.57 | -37.25 | -34.21 | 16.54 | 13.58 | Upgrade
|
| EBITDA Margin | -47.00% | -123.54% | -89.14% | 22.61% | 19.86% | Upgrade
|
| D&A For EBITDA | 0.3 | 0.3 | 0.26 | 0.44 | 0.87 | Upgrade
|
| EBIT | -15.87 | -37.55 | -34.47 | 16.1 | 12.71 | Upgrade
|
| EBIT Margin | -47.92% | -124.55% | -89.82% | 22.01% | 18.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.